Pure Global
NCT06070922

LDCT Chest In Assessment Of Apparently Healthy Smokers

Role Of LDCT Chest In Assessment Of Apparently Healthy Smokers
Assiut University·ClinicalTrials.govNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Smoking
Study type
Observational
Sponsor & location
Primary sponsor
Assiut University
Timeline & enrollment
Phase
N/A
Start date
Oct 20, 2023
End date
Dec 20, 2024
Enrollment
100 participants
Primary outcome

• Prevalence of Emphysema in apparently healthy smoker • Association between lung cancer and emphysema • Rate of early-stage lung cancer detection (Stage I/II) • Lung cancer mortality rate

Summary

To evaluate the effectiveness of LDCT screening in detecting early-stage lung cancers among
 smokers who do not have symptoms of lung disease.

ICD-10 classifications
Tobacco useExposure to tobacco smokeToxic effect: Tobacco and nicotineMental and behavioural disorders due to use of tobacco : harmful useDrug use
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06070922
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06070922 through Pure Global AI's free database. This phase not specified trial is sponsored by Assiut University and is currently Not yet recruiting. The study focuses on Smoking. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.